A detailed history of Northwestern Mutual Investment Management Company, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Northwestern Mutual Investment Management Company, LLC holds 3,363 shares of REGN stock, worth $2.56 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,363
Previous 3,375 0.36%
Holding current value
$2.56 Million
Previous $3.55 Million 0.34%
% of portfolio
0.08%
Previous 0.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1024.09 - $1201.76 $12,289 - $14,421
-12 Reduced 0.36%
3,363 $3.54 Million
Q2 2024

Aug 15, 2024

BUY
$883.2 - $1071.19 $20,313 - $24,637
23 Added 0.69%
3,375 $3.55 Million
Q1 2024

May 15, 2024

SELL
$902.69 - $993.35 $35,204 - $38,740
-39 Reduced 1.15%
3,352 $3.23 Million
Q4 2023

Feb 13, 2024

BUY
$775.18 - $881.7 $17,053 - $19,397
22 Added 0.65%
3,391 $2.98 Million
Q3 2023

Nov 14, 2023

SELL
$692.45 - $844.37 $24,235 - $29,552
-35 Reduced 1.03%
3,369 $2.77 Million
Q2 2023

Aug 14, 2023

BUY
$700.03 - $830.35 $16,800 - $19,928
24 Added 0.71%
3,404 $2.45 Million
Q1 2023

May 15, 2023

BUY
$680.49 - $826.97 $15,651 - $19,020
23 Added 0.69%
3,380 $2.78 Million
Q4 2022

Feb 21, 2023

SELL
$705.89 - $766.39 $440,475 - $478,227
-624 Reduced 15.67%
3,357 $2.42 Million
Q3 2022

Nov 14, 2022

SELL
$573.97 - $724.32 $467,785 - $590,320
-815 Reduced 16.99%
3,981 $2.74 Million
Q2 2022

Aug 04, 2022

BUY
$548.35 - $738.84 $35,642 - $48,024
65 Added 1.37%
4,796 $2.84 Million
Q1 2022

May 09, 2022

SELL
$595.12 - $698.43 $298,750 - $350,611
-502 Reduced 9.59%
4,731 $3.3 Million
Q4 2021

Feb 03, 2022

SELL
$543.48 - $670.97 $17,934 - $22,142
-33 Reduced 0.63%
5,233 $3.31 Million
Q3 2021

Nov 15, 2021

BUY
$574.03 - $680.96 $293,329 - $347,970
511 Added 10.75%
5,266 $3.19 Million
Q2 2021

Aug 13, 2021

SELL
$472.8 - $558.54 $8,510 - $10,053
-18 Reduced 0.38%
4,755 $2.66 Million
Q1 2021

May 14, 2021

SELL
$446.73 - $548.2 $438,242 - $537,784
-981 Reduced 17.05%
4,773 $2.26 Million
Q4 2020

Feb 12, 2021

BUY
$478.3 - $607.98 $101,877 - $129,499
213 Added 3.84%
5,754 $2.78 Million
Q2 2020

Aug 14, 2020

BUY
$493.32 - $643.92 $682,261 - $890,541
1,383 Added 33.26%
5,541 $3.46 Million
Q1 2020

May 08, 2020

BUY
$336.18 - $494.43 $355,006 - $522,118
1,056 Added 34.04%
4,158 $2.03 Million
Q4 2019

Feb 07, 2020

BUY
$274.13 - $376.51 $16,173 - $22,214
59 Added 1.94%
3,102 $1.17 Million
Q3 2019

Nov 06, 2019

BUY
$273.46 - $318.39 $16,407 - $19,103
60 Added 2.01%
3,043 $844,000
Q2 2019

Aug 12, 2019

SELL
$299.6 - $414.82 $2.67 Million - $3.7 Million
-8,926 Reduced 74.95%
2,983 $934,000
Q1 2019

May 10, 2019

BUY
$372.08 - $439.57 $80,741 - $95,386
217 Added 1.86%
11,909 $4.89 Million
Q4 2018

Feb 13, 2019

SELL
$335.82 - $403.04 $626,975 - $752,475
-1,867 Reduced 13.77%
11,692 $4.37 Million
Q3 2018

Nov 13, 2018

SELL
$351.14 - $408.51 $439,627 - $511,454
-1,252 Reduced 8.45%
13,559 $5.48 Million
Q2 2018

Aug 14, 2018

BUY
$284.6 - $344.99 $214,873 - $260,467
755 Added 5.37%
14,811 $5.11 Million
Q1 2018

May 14, 2018

SELL
$315.82 - $393.78 $1.06 Million - $1.32 Million
-3,344 Reduced 19.22%
14,056 $4.84 Million
Q4 2017

Feb 13, 2018

BUY
$358.63 - $469.95 $63,118 - $82,711
176 Added 1.02%
17,400 $6.54 Million
Q3 2017

Nov 13, 2017

SELL
$431.38 - $504.0 $112,590 - $131,544
-261 Reduced 1.49%
17,224 $7.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
14,516 Added 488.92%
17,485 $8.59 Million
Q2 2017

Aug 09, 2017

BUY
N/A
2,969
2,969 $1.04 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Northwestern Mutual Investment Management Company, LLC Portfolio

Follow Northwestern Mutual Investment Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Investment Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Investment Management Company, LLC with notifications on news.